{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:06:12Z","timestamp":1740175572008,"version":"3.37.3"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bolet\u00edn M\u00e9dico del Hospital Infantil de M\u00e9xico"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.bmhimx.2017.05.004","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T21:16:24Z","timestamp":1503695784000},"page":"324-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepatitis autoinmune en la edad pedi\u00e1trica"],"prefix":"10.1016","volume":"74","author":[{"given":"Rub\u00e9n","family":"Pe\u00f1a-V\u00e9lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enory","family":"Almanza-Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmhimx.2017.05.004_bib0475","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1478-3231.2011.02603.x","article-title":"Autoimmune hepatitis from the paediatric perspective","volume":"31","author":"Roberts","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0480","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/apt.12470","article-title":"Review article: autoimmune hepatitis - current management and challenges","volume":"38","author":"Zachou","year":"2013","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0485","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4254\/wjh.v6.i7.464","article-title":"Juvenile autoimmune hepatitis: Spectrum of the disease","volume":"6","author":"Maggiore","year":"2014","journal-title":"World J Hepatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0490","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1573396052953499","article-title":"Autoimmune hepatitis: A chilhood disease","volume":"1","author":"Maggiore","year":"2005","journal-title":"Curr Pediatr Rev."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0495","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/0891693021000056712","article-title":"Anti-soluble liver antigen\/liver-pancreas (SLA\/LP) antibodies in pediatric patients with autoimmune hepatitis","volume":"35","author":"Vitozzi","year":"2002","journal-title":"Autoimmunity."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0500","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2004.11.009","article-title":"Clinical features and biochemical data of Caucasian children at diagnosis of autoimmune hepatitis","volume":"24","author":"Oettinger","year":"2005","journal-title":"J Autoimmun."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0505","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.dld.2016.03.015","article-title":"Seronegative autoimmune hepatitis in children: Spectrum of disorders","volume":"48","author":"Maggiore","year":"2016","journal-title":"Dig Liver Dis."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0510","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0029-1233529","article-title":"Autoimmune hepatitis in children: what is different from adult AIH?","volume":"29","author":"Mieli-Vergani","year":"2009","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0515","first-page":"238","article-title":"Hepatitis autoinmune en ni\u00f1os: evoluci\u00f3n de 20 casos del norte de M\u00e9xico","volume":"79","author":"Nares-Cisneros","year":"2014","journal-title":"Rev Gastroenterol Mex."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0520","first-page":"1","article-title":"Epidemiology and treatment of autoimmune hepatitis","volume":"4","author":"Francque","year":"2012","journal-title":"Hepat Med."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0525","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1499-3872(12)60136-2","article-title":"Association of polymorphisms in non-classic MHC genes with susceptibility to autoimmune hepatitis","volume":"11","author":"Tang","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0530","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0535","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1600-0528.2002.017401.x","article-title":"Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis","volume":"174","author":"Czaja","year":"2000","journal-title":"Immunol Rev."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0540","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0168-8278(02)00182-4","article-title":"Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States","volume":"37","author":"Czaja","year":"2002","journal-title":"J Hepatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0545","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1478-3231.2007.01581.x","article-title":"Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela","volume":"27","author":"Fortes Mdel","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0550","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0198-8859(94)90008-6","article-title":"Chronic active autoimmune hepatitis in children, Strong association with a particular HLA-DR6 (DRB1*1301) haplotype","volume":"41","author":"Fainboim","year":"1994","journal-title":"Hum Immunol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0555","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.510300611","article-title":"Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition","volume":"30","author":"Pando","year":"1999","journal-title":"Hepatology."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0560","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1572-0241.1999.01229.x","article-title":"Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2","volume":"94","author":"Bittencourt","year":"1999","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0565","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.trsl.2006.11.010","article-title":"Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis","volume":"149","author":"Lapierre","year":"2007","journal-title":"Transl Res."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0570","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J Immunol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0575","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.23792","article-title":"A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis","volume":"52","author":"Ferri","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0580","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.3748\/wjg.v19.i28.4455","article-title":"Autoimmune hepatitis in childhood: The role of genetic and immune factors","volume":"19","author":"Ferri Liu","year":"2013","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0585","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.22071","article-title":"Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis","volume":"47","author":"Longhi","year":"2008","journal-title":"Hepatology."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0590","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.it.2006.05.003","article-title":"CD4+CD25+ Tregs and NKT cells: regulators regulating regulators","volume":"27","author":"La Cava","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0595","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1002\/eji.200425071","article-title":"CCL3\/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver","volume":"34","author":"Ajuebor","year":"2004","journal-title":"Eur J Immunol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0600","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1440-1746.2000.02044.x","article-title":"Increase in CD95 (Fas\/APO-1)-positive CD4+ and CD8+ T cells in peripheral blood derived from patients with autoimmune hepatitis or chronic hepatitis C with autoimmune phenomena","volume":"15","author":"Ogawa","year":"2000","journal-title":"J Gastroenterol Hepatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0605","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","article-title":"Autoimmune hepatitis, one disease with many faces: Etiopathogenetic, clinico-laboratory and histological characteristics","volume":"21","author":"Gatselis","year":"2015","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0610","first-page":"390916","article-title":"Autoimmune hepatitis: A review of current diagnosis and treatment","volume":"2011","author":"Makol","year":"2011","journal-title":"Hepat Res Treat."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0615","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1824-7288-36-73","article-title":"HLA-DRB1 as a risk factor in children with autoimmune hepatitis and its relation to hepatitis A infection","volume":"36","author":"Elfaramawy","year":"2010","journal-title":"Ital J Pediatr."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0620","first-page":"230","article-title":"Toxicidad hep\u00e1tica inducida por f\u00e1rmacos y herbolaria","volume":"75","author":"Higuera-de la Tijera","year":"2012","journal-title":"Rev Med Hosp Gen Mex."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0625","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0630","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.3748\/wjg.15.2960","article-title":"Systemic abnormalities in liver disease","volume":"15","author":"Minemura","year":"2009","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0635","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.08.004","article-title":"Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review","volume":"46","author":"Floreani","year":"2013","journal-title":"J Autoimmun."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0640","first-page":"302","article-title":"Autoimmune hepatitis in children: experiences in a tertiary center","volume":"23","author":"Dehghani","year":"2013","journal-title":"Iran J Pediatr."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0645","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MCG.0b013e3181c74e0d","article-title":"Concurrent autoimmune diseases in patients with autoimmune hepatitis","volume":"44","author":"Teufel","year":"2010","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0650","doi-asserted-by":"crossref","first-page":"12662","DOI":"10.3748\/wjg.v20.i35.12662","article-title":"Association of autoimmune hepatitis and systemic lupus erythematodes: A case series and review of the literature","volume":"20","author":"Beisel","year":"2014","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0655","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12969-015-0046-4","article-title":"Autoimmune hepatitis as a presenting manifestation of mixed connective tissue disease in a child Case report and review of the literature","volume":"13","author":"Sedej","year":"2015","journal-title":"Pediatr Rheumatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0660","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1758-5996-6-38","article-title":"Autoimmune hepatitis related autoantibodies in children with type 1 diabetes","volume":"6","author":"Al-Hussaini","year":"2014","journal-title":"Diabetol Metab Syndr."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0665","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s10620-015-3699-4","article-title":"Clinical presentation and outcomes of autoimmune hepatitis in inflammatory bowel disease","volume":"60","author":"DeFilippis","year":"2015","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0670","first-page":"723","article-title":"Prevalence of celiac disease in children with autoimmune hepatitis and vice versa","volume":"24","author":"Najafi","year":"2014","journal-title":"Iran J Pediatr."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0675","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2169\/internalmedicine.56.7506","article-title":"Autoimmune hepatitis associated with immune thrombocytopenic purpura","volume":"56","author":"Ito","year":"2017","journal-title":"Intern Med."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0680","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0685","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cgh.2011.11.030","article-title":"Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children","volume":"10","author":"Mileti","year":"2012","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0690","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.3748\/wjg.v18.i33.4470","article-title":"Diagnostic criteria for autoimmune hepatitis in children: a challenge for pediatric hepatologists","volume":"18","author":"Ferri","year":"2012","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0695","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.3748\/wjg.v19.i23.3629","article-title":"Role of international criteria in the diagnosis of autoimmune hepatitis","volume":"19","author":"Abdollahi","year":"2013","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0700","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2036.2011.04908.x","article-title":"Anti-\u03b1 actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1","volume":"35","author":"Zachou","year":"2012","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0705","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatology."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0710","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1542-3565(04)00354-4","article-title":"Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody","volume":"2","author":"Bridoux-Henno","year":"2004","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0715","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1023\/A:1024748714580","article-title":"Frequency and significance of antibodies to chromatin in autoimmune hepatitis","volume":"48","author":"Czaja","year":"2003","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0720","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-1-2","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease","volume":"1","author":"Zachou","year":"2004","journal-title":"J Autoimmune Dis."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0725","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1572-0241.2001.03383.x","article-title":"LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity","volume":"96","author":"Csepregi","year":"2001","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0730","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cld.301","article-title":"Autoimmune hepatitis: Histopathology","volume":"3","author":"Geller","year":"2014","journal-title":"Clin Liver Dis."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0735","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0740","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000440747","article-title":"Role of histopathology in autoimmune hepatitis","volume":"33","author":"Tiniakos","year":"2015","journal-title":"Dig Dis."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0745","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/hep.22261","article-title":"Diagnosis and treatment of Wilson disease: an update","volume":"47","author":"Roberts","year":"2008","journal-title":"Hepatology."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0750","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/TACG.S10604","article-title":"Alpha1-antitrypsin deficiency: a clinical-genetic overview","volume":"4","author":"Abboud","year":"2011","journal-title":"Appl Clin Genet."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0755","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.3748\/wjg.14.3360","article-title":"Autoimmune paediatric liver disease","volume":"14","author":"Mieli-Vergani","year":"2008","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0760","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0765","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/14656566.2011.524206","article-title":"Pharmacological management of autoimmune hepatitis","volume":"12","author":"Vergani","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0770","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00281-009-0170-7","article-title":"Autoimmune hepatitis","volume":"31","author":"Vergani","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0775","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/MEG.0b013e328353750c","article-title":"Autoimmune hepatitis in children: an overview of the disease focusing on current therapies","volume":"24","author":"Della Corte","year":"2012","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0780","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0168-8278(00)00095-7","article-title":"Duration of immunosuppressive therapy in autoimmune hepatitis (AIH)","volume":"34","author":"Kanzler","year":"2001","journal-title":"J Hepatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0785","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jhep.2010.12.012","article-title":"Autoimmune hepatitis","volume":"55","author":"Lohse","year":"2011","journal-title":"J Hepatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0790","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.mpg.0000239735.87111.ba","article-title":"Prospective analysis of nonadherence in autoimmune hepatitis: a common problem","volume":"43","author":"Kerkar","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0795","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3748\/wjg.v12.i9.1362","article-title":"Budesonide induces complete remission in autoimmune hepatitis","volume":"12","author":"Csepregi","year":"2006","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0800","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jpeds.2013.05.042","article-title":"Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents","volume":"163","author":"Woynarowski","year":"2013","journal-title":"J Pediatr."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0805","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/1756283X12450251","article-title":"Management of patients with difficult autoimmune hepatitis","volume":"5","author":"Parker","year":"2012","journal-title":"Therap Adv Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0810","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2009.02.024","article-title":"Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow up","volume":"51","author":"Aw","year":"2009","journal-title":"J Hepatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0815","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jhep.2011.01.012","article-title":"Role of mycophenolate mofetil in the treatment of autoimmune hepatitis","volume":"55","author":"Schramm","year":"2011","journal-title":"J Hepatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0820","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","author":"Gleeson","year":"2011","journal-title":"Gut."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0825","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(99)80065-8","article-title":"Short-term cyclosporine induces a remission of autoimmune hepatitis in children","volume":"30","author":"Alvarez","year":"1999","journal-title":"J Hepatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0830","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2036.2011.04749.x","article-title":"Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience","volume":"34","author":"Tannous","year":"2011","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0835","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.mcg.0000139050.67178.be","article-title":"Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis","volume":"38","author":"Aqel","year":"2004","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0840","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3748\/wjg.v13.i23.3232","article-title":"Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis","volume":"13","author":"Larsen","year":"2007","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0845","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.endomx.2016.10.001","article-title":"Vasculitis gastrointestinal en una adolescente con lupus eritematoso sist\u00e9mico y s\u00edndrome antifosfol\u00edpido catastr\u00f3fico","volume":"28","author":"Pe\u00f1a","year":"2016","journal-title":"Endoscopia."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0850","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000322693","article-title":"A Case of autoimmune hepatitis treated with rituximab","volume":"4","author":"Barth","year":"2010","journal-title":"Case Rep Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0855","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2013\/512624","article-title":"Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy","volume":"27","author":"Burak","year":"2013","journal-title":"Can J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0860","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/imt.10.67","article-title":"Anti-TNF-\u03b1 agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls","volume":"2","author":"Silva","year":"2010","journal-title":"Imunotherapy."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0865","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2036.2010.04316.x","article-title":"Anti TNF-alpha therapy can be a novel treatment option in patients with autoimmune hepatitis","volume":"32","author":"Efe","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0870","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2169\/internalmedicine.50.4879","article-title":"Improvement of rheumatoid arthritis and autoimmune hepatitis in a patient treated with the tumor necrosis factor inhibitor, etanercept","volume":"50","author":"Umekita","year":"2011","journal-title":"Intern Med."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0875","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ibd.21336","article-title":"Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-\u03b1) use for inflammatory bowel disease","volume":"17","author":"Coffin","year":"2011","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0880","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF01211187","article-title":"Effects of ursodeoxycholic acid and chenodeoxycholic acid on major histocompatibility complex class I gene expression","volume":"31","author":"Hirano","year":"1996","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0885","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.510300603","article-title":"Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial","volume":"30","author":"Czaja","year":"1999","journal-title":"Hepatology."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0890","first-page":"192","article-title":"Ursodeoxycholic acid in treatment of non-cholestatic liver diseases: A systematic review","volume":"4","author":"Reardon","year":"2016","journal-title":"J Clin Transl Hepatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0895","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MPG.0b013e3181bf0ef7","article-title":"Childhood autoimmune liver disease: indications and outcome of liver transplantation","volume":"50","author":"Chai","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0900","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence","volume":"52","author":"Duclos-Valle\u00e9","year":"2003","journal-title":"Gut."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0905","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00365520903555861","article-title":"Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response","volume":"45","author":"Werner","year":"2010","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0910","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrgastro.2011.69","article-title":"Autoimmune hepatitis","volume":"8","author":"Mieli-Vergani","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0915","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","article-title":"Liver transplantation in autoimmune liver diseases","volume":"25","author":"Ilyas","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0920","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/CEG.S101440","article-title":"Autoimmune hepatitis: current challenges and future prospects","volume":"10","author":"Aizawa","year":"2017","journal-title":"Clin Exp Gastroenterol."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0925","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/apt.13907","article-title":"Expert clinical management of autoimmune hepatitis in the real world","volume":"45","author":"Liberal","year":"2017","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0930","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/hep.24039","article-title":"Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis","volume":"53","author":"Longhi","year":"2011","journal-title":"Hepatology."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0935","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.26583","article-title":"Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis","volume":"59","author":"Grant","year":"2014","journal-title":"Hepatology."},{"key":"10.1016\/j.bmhimx.2017.05.004_bib0940","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.2174\/138161211798157568","article-title":"Emerging treatments for autoimmune hepatitis","volume":"17","author":"Czaja","year":"2011","journal-title":"Curr Pharm Des."}],"container-title":["Bolet\u00edn M\u00e9dico del Hospital Infantil de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1665114617300679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1665114617300679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T15:46:47Z","timestamp":1539877607000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665114617300679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1665114617300679"],"URL":"https:\/\/doi.org\/10.1016\/j.bmhimx.2017.05.004","relation":{},"ISSN":["1665-1146"],"issn-type":[{"type":"print","value":"1665-1146"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis autoinmune en la edad pedi\u00e1trica","name":"articletitle","label":"Article Title"},{"value":"Bolet\u00edn M\u00e9dico del Hospital Infantil de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.bmhimx.2017.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Hospital Infantil de M\u00e9xico Federico G\u00f3mez. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}